10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 322 filers reported holding 10X GENOMICS INC in Q1 2021. The put-call ratio across all filers is 1.39 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,543,000 | -33.5% | 37,395 | -10.0% | 0.01% | -22.2% |
| Q2 2023 | $2,319,000 | -9.2% | 41,538 | -9.2% | 0.01% | -18.2% |
| Q1 2023 | $2,553,000 | +48.5% | 45,752 | -3.0% | 0.01% | +57.1% |
| Q4 2022 | $1,719,000 | +30.7% | 47,173 | +2.1% | 0.01% | +16.7% |
| Q3 2022 | $1,315,000 | -35.8% | 46,183 | +2.0% | 0.01% | -33.3% |
| Q2 2022 | $2,049,000 | -38.7% | 45,279 | +3.1% | 0.01% | -25.0% |
| Q1 2022 | $3,342,000 | -50.7% | 43,933 | -3.5% | 0.01% | -47.8% |
| Q4 2021 | $6,778,000 | -0.3% | 45,504 | -2.5% | 0.02% | -4.2% |
| Q3 2021 | $6,797,000 | -27.3% | 46,686 | -2.2% | 0.02% | -27.3% |
| Q2 2021 | $9,348,000 | +69.3% | 47,737 | +56.5% | 0.03% | +50.0% |
| Q1 2021 | $5,521,000 | +38.2% | 30,501 | +8.1% | 0.02% | +22.2% |
| Q4 2020 | $3,996,000 | +41.6% | 28,219 | +24.7% | 0.02% | +20.0% |
| Q3 2020 | $2,822,000 | +52.3% | 22,630 | +9.0% | 0.02% | +36.4% |
| Q2 2020 | $1,853,000 | – | 20,752 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |